Home Cart 0 Sign in  
X

[ CAS No. 31839-20-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 31839-20-0
Chemical Structure| 31839-20-0
Chemical Structure| 31839-20-0
Structure of 31839-20-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 31839-20-0 ]

Related Doc. of [ 31839-20-0 ]

Alternatived Products of [ 31839-20-0 ]

Product Details of [ 31839-20-0 ]

CAS No. :31839-20-0 MDL No. :MFCD10666941
Formula : C8H7NO6 Boiling Point : -
Linear Structure Formula :- InChI Key :VAFJDIUJDDCMHN-UHFFFAOYSA-N
M.W : 213.14 Pubchem ID :13915669
Synonyms :

Calculated chemistry of [ 31839-20-0 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 3
Num. H-bond acceptors : 6.0
Num. H-bond donors : 2.0
Molar Refractivity : 50.74
TPSA : 112.58 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.97 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.98
Log Po/w (XLOGP3) : 0.89
Log Po/w (WLOGP) : 1.01
Log Po/w (MLOGP) : -0.24
Log Po/w (SILICOS-IT) : -1.34
Consensus Log Po/w : 0.26

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.82
Solubility : 3.22 mg/ml ; 0.0151 mol/l
Class : Very soluble
Log S (Ali) : -2.84
Solubility : 0.309 mg/ml ; 0.00145 mol/l
Class : Soluble
Log S (SILICOS-IT) : -0.71
Solubility : 41.4 mg/ml ; 0.194 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.13

Safety of [ 31839-20-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 31839-20-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 31839-20-0 ]
  • Downstream synthetic route of [ 31839-20-0 ]

[ 31839-20-0 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 26791-93-5 ]
  • [ 31839-20-0 ]
YieldReaction ConditionsOperation in experiment
92%
Stage #1: at 0 - 70℃; for 4 h; Heating / reflux
Stage #2: With acetic acid In water at 20℃;
770 g (11.665 mol) of KOH pellets (w=85percent) are dissolved in 4000 ml of ice water. 800 g (3.317 mol) methyl-4,5-dimethoxy-2-nitro-benzoate (1) are added to the clear solution and the resulting green suspension is refluxed. During the heating a red solution is formed. The solution is refluxed with stirring for about 4 h while distilling off 850 ml of methanol/water. Once the reaction is complete (monitored by HPLC) the solution is cooled to ambient temperature and adjusted to pH 9 with 337.6 g (5.566 mol) glacial acetic acid. The nitro group reduction and isolation of the product (2) were carried out analogously to Ex. 1.The reaction yielded 558.5 g (3.049 mol, 92percent of theory) in the form of grey crystals.
Reference: [1] Patent: US2008/319194, 2008, A1, . Location in patent: Page/Page column 5
[2] Journal of the Chemical Society, 1932, p. 1370,1375
[3] ChemMedChem, 2014, vol. 9, # 7, p. 1476 - 1487
[4] Patent: WO2018/119441, 2018, A1, . Location in patent: Paragraph 00556; 00557
  • 2
  • [ 4998-07-6 ]
  • [ 31839-20-0 ]
YieldReaction ConditionsOperation in experiment
99%
Stage #1: at 100℃; for 3 h;
Stage #2: With hydrogenchloride In water at 0℃;
5-hvdroxy-4-methoxy-2-nitrobenzoic acid: A mixture of 4,5- dimethoxy-2-nitrobenzoic acid (15 g, 66 mmol) in aqueous sodium hydroxide (6 M, 60 mL) was heated at 1000C for 3 h, was cooled to room temperature, and was poured into a mixture of concentrated hydrochloric acid and crushed ice (pH <2). The mixture was extracted with ethylacetate, was washed with brine, was dried over magnesium sulfate, was filtered, and was concentrated in vacuo to afford 14 g (99percent yield) of the title compound; 13C NMR (101 MHz, Methanol-D4) d 55.82, 107.46, 114.98, 122.90, 140.33, 149.09, 151.13, 167.96; MS (AP/CI): 212 (M-H)-.
95%
Stage #1: at 100℃; for 12 h;
Stage #2: Cooling with ice
Example 1 1; Preparation of 1 -(5-tert-butylisoxazol-3-yl)-3-(3-(6-ethoxy-7-methoxyquinazolin-4- yloxy)phenyl)urea; [00689] Example 1 IA Step 1 : A mixture of 4,5-dimethoxy-2-nitrobenzoic acid(20.6 g, 90.7 mmol) in 20percent KOH solution (136 mL) was heated at 100 °C for 12 hours. After it was cooled with ice, it was acidified with concentrated HCl to pH 2. It was filtered, washed with CH2Cl2 and EtOAc, and dried over vacuum to afford 5- hydroxy-4-methoxy-2-nitrobenzoic acid as solid (18.38 g, 95percent). 1H NMR (300 MHz, DMSO-d6) δ 7.29 (s, 1H), 6.90 (s, 1H), 4.8 (br, 1H), 3.77 (s, 3H).
79% With hydrogenchloride In water at 100℃; for 3 h; To 4,5-dimethoxy-2-nitro- benzoic acid was added 6 M HCI (60 mL). The resultant yellow mixture was heated to 100 0C for 3 h, and then cooled to rt. The resultant solid was dissolved in 100 mL of water and poured into a slurry of 9 M HCI and crushed ice. The mixture was extracted twice with ethyl acetate and the combined extracts were washed with brine, dried over magnesium sulfate, and concentrated to give 14.7 g of a pale yellow solid. Recrystallization from ethyl acetate/hexanes provided 10.8 g (79percent) of the title compound.
79% With sodium hydroxide In water at 100℃; for 3 h; To 4,5-Dimethoxy-2-nitro-benzoic acid was added 6 M NaOH (60 mL). The resultant yellow mixture was heated to 100° C. for 3 h, and then cooled to rt. The resultant solid was dissolved in 100 mL of water and poured into a slurry of 9 M HCl and crushed ice. The mixture was extracted twice with ethyl acetate and the combined extracts were washed with brine, dried over magnesium sulfate, and concentrated to give 14.7 g of a pale yellow solid. Recrystallization from ethyl acetate/hexanes provided 10.8 g (79percent) of the title compound.

Reference: [1] Patent: WO2008/20302, 2008, A2, . Location in patent: Page/Page column 28
[2] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4536 - 4547
[3] Patent: WO2009/117080, 2009, A1, . Location in patent: Page/Page column 172
[4] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 15, p. 5489 - 5497
[5] Tetrahedron, 2005, vol. 61, # 39, p. 9375 - 9380
[6] Patent: WO2006/70284, 2006, A1, . Location in patent: Page/Page column 34
[7] Patent: US2006/19975, 2006, A1, . Location in patent: Page/Page column 16
[8] Patent: WO2010/76810, 2010, A2, . Location in patent: Page/Page column 15
[9] Patent: WO2014/135876, 2014, A1, . Location in patent: Page/Page column 35
[10] Patent: US2014/255428, 2014, A1, . Location in patent: Paragraph 0212-0213
  • 3
  • [ 31839-20-0 ]
  • [ 788136-89-0 ]
Reference: [1] Patent: WO2018/119441, 2018, A1,
  • 4
  • [ 31839-20-0 ]
  • [ 286371-64-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4536 - 4547
[2] ChemMedChem, 2014, vol. 9, # 7, p. 1476 - 1487
  • 5
  • [ 31839-20-0 ]
  • [ 612501-52-7 ]
Reference: [1] Patent: WO2014/135876, 2014, A1,
[2] Patent: US2014/255428, 2014, A1,
  • 6
  • [ 31839-20-0 ]
  • [ 164161-49-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4536 - 4547
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 31839-20-0 ]

Aryls

Chemical Structure| 164161-49-3

[ 164161-49-3 ]

Methyl 5-benzyloxy-4-methoxy-2-nitrobenzoate

Similarity: 0.95

Chemical Structure| 61032-41-5

[ 61032-41-5 ]

Methyl 4-(benzyloxy)-5-methoxy-2-nitrobenzoate

Similarity: 0.95

Chemical Structure| 2327-45-9

[ 2327-45-9 ]

Methyl 5-methoxy-2-nitrobenzoate

Similarity: 0.93

Chemical Structure| 78238-12-7

[ 78238-12-7 ]

3-Methoxy-5-nitrobenzoic acid

Similarity: 0.93

Chemical Structure| 74230-08-3

[ 74230-08-3 ]

4-Hydroxy-2-nitrobenzoic acid

Similarity: 0.91

Ethers

Chemical Structure| 164161-49-3

[ 164161-49-3 ]

Methyl 5-benzyloxy-4-methoxy-2-nitrobenzoate

Similarity: 0.95

Chemical Structure| 61032-41-5

[ 61032-41-5 ]

Methyl 4-(benzyloxy)-5-methoxy-2-nitrobenzoate

Similarity: 0.95

Chemical Structure| 2327-45-9

[ 2327-45-9 ]

Methyl 5-methoxy-2-nitrobenzoate

Similarity: 0.93

Chemical Structure| 78238-12-7

[ 78238-12-7 ]

3-Methoxy-5-nitrobenzoic acid

Similarity: 0.93

Chemical Structure| 15785-54-3

[ 15785-54-3 ]

4-Hydroxy-3-methoxy-5-nitrobenzoic acid

Similarity: 0.90

Carboxylic Acids

Chemical Structure| 57672-33-0

[ 57672-33-0 ]

7-Nitro-1,4-benzodioxane-6-carboxylic Acid

Similarity: 0.97

Chemical Structure| 78238-12-7

[ 78238-12-7 ]

3-Methoxy-5-nitrobenzoic acid

Similarity: 0.93

Chemical Structure| 610-37-7

[ 610-37-7 ]

5-Hydroxy-2-nitrobenzoic acid

Similarity: 0.91

Chemical Structure| 74230-08-3

[ 74230-08-3 ]

4-Hydroxy-2-nitrobenzoic acid

Similarity: 0.91

Chemical Structure| 15785-54-3

[ 15785-54-3 ]

4-Hydroxy-3-methoxy-5-nitrobenzoic acid

Similarity: 0.90

Nitroes

Chemical Structure| 57672-33-0

[ 57672-33-0 ]

7-Nitro-1,4-benzodioxane-6-carboxylic Acid

Similarity: 0.97

Chemical Structure| 164161-49-3

[ 164161-49-3 ]

Methyl 5-benzyloxy-4-methoxy-2-nitrobenzoate

Similarity: 0.95

Chemical Structure| 61032-41-5

[ 61032-41-5 ]

Methyl 4-(benzyloxy)-5-methoxy-2-nitrobenzoate

Similarity: 0.95

Chemical Structure| 2327-45-9

[ 2327-45-9 ]

Methyl 5-methoxy-2-nitrobenzoate

Similarity: 0.93

Chemical Structure| 78238-12-7

[ 78238-12-7 ]

3-Methoxy-5-nitrobenzoic acid

Similarity: 0.93